Answers are grounded in this paper and cite their sources.
Purpose: The use of transdermal fentanyl in postoperative analgesia is controversial and randomized clinical trials are needed to advance knowledge in this setting. We evaluated the perioperative effects of transdermal fentanyl adjusted to patient´s weight applied 8h before spinal fusion. Methods: Prospective, randomized, double-blind, placebo-controlled study. Fifty-two adults received a patch with 1.5 µg·kg-l transdermal fentanyl or saline 8 h before surgery, that was removed 72 h after application. Pain intensity, analgesic consumption, respiratory and cardiovascular parameters, sedation, and adverse event were assessed. Results: Transdermal fentanyl produced analgesia at rest and on movement, decreasing the requirements of ketorolac, tramadol and morphine ; overall analgesic consumption in morphine equivalents was 39.2±28.1 mg versus 101.0±31.9 mg . Before surgery, sub-analgesic fentanyl plasma concentrations decreased respiratory rate in 19% of patients . Plasma concentrations at 16 h and 32 h were 0.67±0.27 ng.ml-l and 1.27±0.45 ng·ml-l . Comparison at these time-points showed improved respiratory rate , minute ventilation and sedation with increased pruritus . At 46 h one patient experienced sedation and bradypnea, requiring naloxone. Conclusions: Transdermal fentanyl adjusted to weight and applied 8 h before surgery, induces prolonged postoperative analgesia, decreasing by 60% analgesic requirements. Slight sedation and decreased respiratory rate unrelated to plasma levels were also present; respiratory depression was observed in 3.8% of patients. Transdermal fentanyl could be useful in painful surgeries, continuous monitoring required for at least 48 h.
No takes yet. Share an insight, caveat, or question.
Barrera et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: